Annual report pursuant to Section 13 and 15(d)

Stock Options and Restricted Stock Units

v3.8.0.1
Stock Options and Restricted Stock Units
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Options and Restricted Stock Units

NOTE 11 – STOCK OPTIONS AND RESTRICTED STOCK UNITS

 

On July 31, 2014, the Board of Directors of Q2P approved the Founders Stock Option Plan (“Founders Plan”) and the 2014 Employee Stock Option Plan (the “2014 Plan”), collectively the “Option Plans”. The Option Plans were developed to provide a means whereby directors and selected employees, officers, consultants, and advisors of the Company may be granted incentive or non-qualified stock options to purchase restricted common stock of the Company. On February 25, 2016, to accommodate the appointment of new Board members and additional incentive stock options and stock grants to key employees of the Company, the Board approved the 2016 Omnibus Equity Incentive Plan (“2016 Plan”), which allowed for an additional 4 million shares of common stock, stock options, stock rights (restricted stock units), or stock appreciation rights to be granted by the Board in its discretion.

 

In May 2017, the Company issued 400,000 common stock options under the 2016 Plan to one new Board member and 400,000 common stock options under the 2016 Plan to one new Board of Advisor Member. The options vest one-half immediately and the balance in 6 months, with a 10-year term and exercisable at $0.21 per share. The options were valued at $96,800 (pursuant to the Black Scholes valuation model, and as shown in the table detailing the calculation of fair value below), based on an exercise price of $0.21 per share and with a maturity life of 5.25 years.

 

For the year ended December 31, 2017, the charge to the consolidated statements of operations for the amortization of stock option grants awarded under the Option Plans and 2016 Plan and for warrants was $236,149.

 

A summary of the common stock options issued under the Option Plans and the 2016 Plan for the period from December 31, 2015 through December 31, 2017 follows:

 

    Number Outstanding     Weighted Avg. Exercise Price     Weighted Avg. Remaining Contractual Life (Years)  
Balance, December 31, 2015     1,745,480     $ 0.30       7.1  
Options issued     4,410,000       0.21       3.5  
Options exercised                  
Options cancelled     (40,000 )     0.30       5.1  
Balance, December 31, 2016     6,115,480     $ 0.21       7.1  
                         
Options issued     800,000       0.21       9.2  
Options exercised                  
Options cancelled                  
Balance, December 31, 2017     6,915,480     $ 0.21       5.6  

  

The vested and exercisable options at period end follows:

 

    Exercisable/
Vested
Options Outstanding
    Weighted Avg.
Exercise Price
    Weighted
Avg.
Remaining Contractual
Life (Years)
 
Balance, December 31, 2017     6,828,813     $ 0.21       5.6  
                         

  

The fair value of new stock options and warrants granted using the Black-Scholes option pricing model was calculated using the following assumptions:

 

    Year Ended
December 31, 2017
 
Risk free interest rate     1.28-1.84 %
Expected volatility     101.2-125.0 %
Expected dividend yield     0 %
Expected term in years     2.08-5.25  
Average value per options   $ 0.04-0.08  

 

Expected volatility is based on historical volatility of the Company’s own common stock. Short Term U.S. Treasury rates were utilized as the risk free interest rate. The expected term of the options was calculated using the alternative simplified method codified as ASC 718 “Accounting for Stock Based Compensation,” which defined the expected life as the average of the contractual term of the options and the weighted average vesting period for all issuances.